coxeta fc tablets 90mg
dch auriga (malaysia) sdn. bhd. - etoricoxib -
coxeta fc tablets 120mg
dch auriga (malaysia) sdn. bhd. - etoricoxib -
alikval duo 50 mg/850 mg film-coated tablets
egis pharmaceuticals plc kereszturi ut 30-38 1106 budapest, hungary - vildagliptin, metformin hydrochloride - film-coated tablet - metformin hydrochloride 850 mg vildagliptin 50 mg - drugs used in diabetes
alikval duo 50 mg/1000 mg film-coated tablets
egis pharmaceuticals plc kereszturi ut 30-38 1106 budapest, hungary - vildagliptin, metformin hydrochloride - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes
bite registration device, <specify>
wishmed pty ltd -
38582 - bite registration device,
egis emoflon rectal ointment
servier (s) pte ltd - gastroenterology & urology - emoflontm rectal ointment is intended for the treatment of symptoms associated with hemorrhoidal disease and its complications (eg, eczema, anal fissure). it covers and protects the epidermis, and provides care to inflamed, itchy skin, helping to promote skin regeneration. it diminishes the drying out of the skin, which helps in wound healing, and reduces the risk of fissure and injury caused by defecation.
bite registration device, bite rim wax
kerr australia pty ltd - 38602 - bite registration device, bite rim wax - dental impression material. take 1 advanced bite registration is designated for making accurate interocclusal records, making implant transfer coping impressions and to check the fit of castings.
bite registration device, bite rim wax
kerr australia pty ltd - 38602 - bite registration device, bite rim wax - dental impression material. take 1 advanced bite registration is designated for making accurate interocclusal records, making implant transfer coping impressions and to check the fit of castings.
bite registration device, <specify>
open airway dental solutions australia pty ltd -
38582 - bite registration device,
alphapress 25 hydralazine hydrochloride 25mg tablet bottle
alphapharm pty ltd - hydralazine hydrochloride, quantity: 25 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; sodium starch glycollate; disodium edetate; purified talc - this product accepted for registration as 'currently supplied' at the time of commencement of the act. variation to pregnancy statement in product information were approved as specified in the letter of 13 august 1992 from dr bijoy varma. indicated for the treatment of drug resistant, moderate to severe, hypertension. this drug is not a first line antihypertensive drug and is better used in combination with other therapy such as a sympatholytic agent and a diuretic. indications as at 28 november 2001 : hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.